Evidence map›Paper›PMID 31079899›Full record

ArticleAmerican journal of human genetics2019

Bi-allelic Variants in DYNC1I2 Cause Syndromic Microcephaly with Intellectual Disability, Cerebral Malformations, and Dysmorphic Facial Features.

Muhammad Ansar, Farid Ullah, Sohail A Paracha, Darius J Adams, Abbe Lai, Lynn Pais, Justyna Iwaszkiewicz, Francisca Millan, Muhammad T Sarwar, Zehra Agha and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pathogenic variants inmedRxiv : the preprint server for health sciences · 2025
    Article
  5. Exploration of the interaction between dynein intermediate chain and dynactin p150Protein science : a publication of the Protein Society · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Perspective on automatedNeural regeneration research · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 14 institutions in 4 countries.

Muhammad AnsarDepartment of Genetic Medicine and Development, University of Geneva, 1206 Geneva, Switzerland.
Farid UllahCenter for Human Disease Modeling, Duke University Medical Center, Durham, NC 27701, USA; Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering, 38000 Faisalabad, Pakistan; Pakistan Institute of Engineering and Applied Sciences, 45650 Islamabad, Pakistan.
Sohail A ParachaInstitute of Basic Medical Sciences, Khyber Medical University, 25100 Peshawar, Pakistan.
Darius J AdamsAtlantic Health System, Goryeb Children's Hospital, Morristown, NJ 07960, USA.
Abbe LaiHoward Hughes Medical Institute, Chevy Chase, MD 20815, USA; Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, USA; Departments of Neurology and Pediatrics, Harvard Medical School, Center for Life Sciences, Blackfan Circle, Boston, MA 02115, USA.
Lynn PaisMedical and Population Genetics Program, Broad Institute of MIT, Cambridge, MA 02142, USA; Center for Mendelian Genomics, Harvard University, Cambridge, MA 02142, USA.
Justyna IwaszkiewiczSwiss Institute of Bioinformatics, Molecular Modeling Group, Batiment Genopode, Unil Sorge, 1015 Lausanne, Switzerland.
Francisca MillanGeneDx, Gaithersburg, MD 20877, USA.
Muhammad T SarwarInstitute of Basic Medical Sciences, Khyber Medical University, 25100 Peshawar, Pakistan.
Zehra AghaDepartment of Biosciences, COMSATS University, 45500 Islamabad, Pakistan.
Sayyed Fahim ShahDepartment of Medicine, KMU Institute of Medical Sciences, 26000 Kohat, Pakistan.
Azhar Ali QaisarRadiology Department, Lady Reading Hospital, 25000 Peshawar, Pakistan.
Emilie FalconnetDepartment of Genetic Medicine and Development, University of Geneva, 1206 Geneva, Switzerland.
Vincent ZoeteSwiss Institute of Bioinformatics, Molecular Modeling Group, Batiment Genopode, Unil Sorge, 1015 Lausanne, Switzerland; Department of Fundamental Oncology, Lausanne University, Ludwig Institute for Cancer Research, Route de la Corniche 9A, 1066 Epalinges, Switzerland.
Emmanuelle RanzaDepartment of Genetic Medicine and Development, University of Geneva, 1206 Geneva, Switzerland; Service of Genetic Medicine, University Hospitals of Geneva, 1205 Geneva, Switzerland.
Periklis MakrythanasisDepartment of Genetic Medicine and Development, University of Geneva, 1206 Geneva, Switzerland; Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.
Federico A SantoniDepartment of Genetic Medicine and Development, University of Geneva, 1206 Geneva, Switzerland; Department of Endocrinology Diabetes and Metabolism, University Hospital of Lausanne, 1011 Lausanne, Switzerland.
Jawad AhmedInstitute of Basic Medical Sciences, Khyber Medical University, 25100 Peshawar, Pakistan.
Nicholas KatsanisCenter for Human Disease Modeling, Duke University Medical Center, Durham, NC 27701, USA.
Christopher WalshHoward Hughes Medical Institute, Chevy Chase, MD 20815, USA; Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, USA; Departments of Neurology and Pediatrics, Harvard Medical School, Center for Life Sciences, Blackfan Circle, Boston, MA 02115, USA; Medical and Population Genetics Program, Broad Institute of MIT, Cambridge, MA 02142, USA; Center for Mendelian Genomics, Harvard University, Cambridge, MA 02142, USA.
Erica E DavisCenter for Human Disease Modeling, Duke University Medical Center, Durham, NC 27701, USA. Electronic address: erica.davis@duke.edu.
Stylianos E AntonarakisDepartment of Genetic Medicine and Development, University of Geneva, 1206 Geneva, Switzerland; Service of Genetic Medicine, University Hospitals of Geneva, 1205 Geneva, Switzerland; iGE3 Institute of Genetics and Genomics of Geneva, 1211 Geneva, Switzerland. Electronic address: stylianos.antonarakis@unige.ch.
University of Geneva · CHKhyber Medical University · PKBiomedical Research Foundation of the Academy of Athens · GRBroad Institute · USCenter for Human Genetics · USCOMSATS University Islamabad · PKDuke Medical Center · USDuke University Hospital · USGoryeb Children's Hospital · USHoward Hughes Medical Institute · USLady Reading Hospital · PKLudwig Cancer Research · CHPakistan Institute of Engineering and Applied Sciences · PKSIB Swiss Institute of Bioinformatics · CH

Funding

Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
HUMAN EPILEPSY GENETICS--NEURONAL MIGRATION DISORDERSR01NS035129 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI WALSH, CHRISTOPHER A. · 1997 to 2023
$9.5M
Resource for Biocomputing Visualization and InformaticsP41GM103311 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2012 to 2017
$8.2M
Functional Dissection of CNVs in Neurodevelopmental TraitsR01MH106826 · NIMH · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI DAVIS, ERICA ELLEN · 2015 to 2025
$4.6M
NHGRI NIH HHS UM1 HG008900NIGMS NIH HHS P41 GM103311NIMH NIH HHS R01 MH106826NINDS NIH HHS R01 NS035129
6 · The paper itself

Abstract

Cargo transport along the cytoplasmic microtubular network is essential for neuronal function, and cytoplasmic dynein-1 is an established molecular motor that is critical for neurogenesis and homeostasis. We performed whole-exome sequencing, homozygosity mapping, and chromosomal microarray studies in five individuals from three independent pedigrees and identified likely-pathogenic variants in DYNC1I2 (Dynein Cytoplasmic 1 Intermediate Chain 2), encoding a component of the cytoplasmic dynein 1 complex. In a consanguineous Pakistani family with three affected individuals presenting with microcephaly, severe intellectual disability, simplification of cerebral gyration, corpus callosum hypoplasia, and dysmorphic facial features, we identified a homozygous splice donor site variant (GenBank: NM_001378.2:c.607+1G>A). We report two additional individuals who have similar neurodevelopmental deficits and craniofacial features and harbor deleterious variants; one individual bears a c.740A>G (p.Tyr247Cys) change in trans with a 374 kb deletion encompassing DYNC1I2, and an unrelated individual harbors the compound-heterozygous variants c.868C>T (p.Gln290

Indexed as

MutationAdultAllelesAmino Acid SequenceAnimalsChild, PreschoolCraniofacial AbnormalitiesDyneinsExomeExome SequencingFemaleHomozygoteHumansInfantIntellectual DisabilityIntracranial Arteriovenous MalformationsDyneinsapoptosisautosomal recessivedevelopmental delayDYNC1I2dyneindysmorphic facial featuresintellectual disabilitymicrocephalymitotic spindlezebrafish

Identifiers

PMID31079899
PMCPMC6556908
OpenAlexW2943954780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.